SEC Won't Lift Trading Suspension On Chinese Biotech Firm
The U.S. Securities and Exchange Commission has upheld Nasdaq's decision to delist the stock of Shineco Inc. after the Chinese biotech firm repeatedly violated the exchange's listing requirements, rejecting the company's...To view the full article, register now.
Already a subscriber? Click here to view full article